Petros Pharmaceuticals Inc (PTPI)
0.7133
+0.04
(+5.36%)
USD |
NASDAQ |
May 03, 16:00
0.70
-0.01
(-1.86%)
After-Hours: 20:00
Petros Pharmaceuticals Total Return Level: 0.7133 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 0.7133 |
May 02, 2024 | 0.677 |
May 01, 2024 | 0.657 |
April 30, 2024 | 0.676 |
April 29, 2024 | 0.7041 |
April 26, 2024 | 0.6399 |
April 25, 2024 | 0.6399 |
April 24, 2024 | 0.6344 |
April 23, 2024 | 0.6801 |
April 22, 2024 | 0.6502 |
April 19, 2024 | 0.6701 |
April 18, 2024 | 0.6979 |
April 17, 2024 | 0.69 |
April 16, 2024 | 0.705 |
April 15, 2024 | 0.7831 |
April 12, 2024 | 0.8339 |
April 11, 2024 | 0.91 |
April 10, 2024 | 0.8856 |
April 09, 2024 | 0.911 |
April 08, 2024 | 0.9313 |
April 05, 2024 | 0.9251 |
April 04, 2024 | 0.954 |
April 03, 2024 | 0.93 |
April 02, 2024 | 1.07 |
April 01, 2024 | 1.40 |
Date | Value |
---|---|
March 28, 2024 | 1.48 |
March 27, 2024 | 1.45 |
March 26, 2024 | 1.55 |
March 25, 2024 | 1.57 |
March 22, 2024 | 1.50 |
March 21, 2024 | 1.50 |
March 20, 2024 | 1.41 |
March 19, 2024 | 1.45 |
March 18, 2024 | 1.47 |
March 15, 2024 | 1.52 |
March 14, 2024 | 1.38 |
March 13, 2024 | 1.435 |
March 12, 2024 | 1.49 |
March 11, 2024 | 1.56 |
March 08, 2024 | 1.63 |
March 07, 2024 | 1.50 |
March 06, 2024 | 1.60 |
March 05, 2024 | 1.51 |
March 04, 2024 | 1.63 |
March 01, 2024 | 1.67 |
February 29, 2024 | 1.72 |
February 28, 2024 | 1.68 |
February 27, 2024 | 1.66 |
February 26, 2024 | 1.58 |
February 23, 2024 | 1.65 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.6344
Minimum
Apr 24 2024
46.80
Maximum
Dec 28 2020
13.19
Average
7.134
Median
Total Return Level Benchmarks
Avalo Therapeutics Inc | 14.36 |
Imunon Inc | 1.33 |
iBio Inc | 1.99 |
Oramed Pharmaceuticals Inc | 2.35 |
Ocugen Inc | 1.33 |